arrow
H

Hajime Uno

Dana-Farber Cancer Institute
H指数:53
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Derivation of a blood count-based machine learning model to prioritise sequencing for high-risk clonal haematopoiesis: a retrospective cohort study

基于血细胞计数推导的机器学习模型以优先考虑高风险克隆性造血的测序:一项回顾性队列研究

2026-09-220
OAAI
Bereaved Caregiver Perspectives on Quality of Care at the End of Life Among Adolescents and Young Adults with Cancer

癌症青少年和青年患者临终关怀的质量:丧亲照护者的观点

2026-08-010
PRE
Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention (‘REVITALIZE’) to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol

“REVITALIZE”远程医疗接纳承诺疗法干预措施在减少接受PARP抑制剂治疗的晚期卵巢癌女性患者疲劳干扰中的随机临床试验:研究方案

2026-04-020
OAAI
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials

现代化合格标准对急性髓系白血病临床试验入组和代表性影响

Blood
IF23.1
2025-10-210
PRE
Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial

抗阻运动结合蛋白质补充剂用于接受新辅助化疗的胰腺癌患者骨骼肌质量:REBUILD试验研究方案

2025-05-020
OA
A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on PatientReported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

一项关于胰腺癌家庭基因检测的吸收和对患者报告的心理结果的影响的两种远程医疗保健模式的随机试验: 遗传教育,风险评估和测试 (GENERATE) 研究

2024-05-012
PRE